Pharmaids Pharmaceuticals
48.82
+1.01(+2.11%)
Market Cap₹172.16 Cr
PE Ratio-10.79
IndustryHealthcare
Company Performance:
1D+2.11%
1M-3.33%
6M-14.80%
1Y-39.04%
5Y+226.56%
View Company Insightsright
More news about Pharmaids Pharmaceuticals
18Sept 25
Pharmaids Pharmaceuticals Divests Entire Stake in Anugraha Chemicals for Rs 6.65 Lakh
Pharmaids Pharmaceuticals Limited has sold its entire 66.50% partnership stake in Anugraha Chemicals to Mrs. Sneha Hadimani for Rs 6,65,000 in cash. The transaction, completed on September 18, 2025, follows shareholder and board approvals. Anugraha Chemicals, which contributed 68.91% to Pharmaids' consolidated revenue and 6.80% to net worth in FY 2025, is no longer a material subsidiary. The total transaction value of Rs 10.50 crore includes capital contributions, loans, and other financial adjustments. Pharmaids has also terminated the Investment Agreement dated January 25, 2023.
06Sept 25
Pharmaids Pharmaceuticals Completes Rs 19.56 Crore Land Sale to Chairman
Pharmaids Pharmaceuticals Limited has sold three land parcels totaling 13,975 square meters in Karnataka's Hirehalli Industrial Area to its Chairman, Dr. S. N. Vinaya Babu, for Rs 19.56 crores. The transaction, completed on September 6, 2025, received necessary approvals including shareholder approval via postal ballot and Board of Directors' approval. The company states this sale will not affect its business operations. Following the transaction, Dr. Babu has made an open offer to public shareholders and will be reclassified as part of the Promoter/Promoter Group upon completion of the offer. The company has complied with all relevant regulatory requirements.
07Aug 25
Pharmaids Pharmaceuticals Open Offer: Acquirers Seek 26% Stake at Rs. 62.15 Per Share
Shankarappa Nagaraja Vinaya Babu and Tumkur Trade Center Private Limited have launched an open offer for Pharmaids Pharmaceuticals Limited. The offer aims to acquire up to 91,69,632 equity shares, representing 26% of the voting share capital, at Rs. 62.15 per share. The total offer value is Rs. 56,98,92,629.80. Reminder advertisements were published on August 7, 2025, in multiple languages. Saffron Capital Advisors Private Limited is managing the offer, which complies with SEBI regulations.
07Aug 25
Open Offer for Pharmaids Pharmaceuticals at ₹62.15 per Share
Shankarappa Nagaraja Vinaya Babu and Tumkur Trade Center Private Limited have made an open offer to acquire up to 91,69,632 equity shares of Pharmaids Pharmaceuticals at ₹62.15 per share, totaling ₹56,98,92,629.00. The offer complies with SEBI regulations on substantial acquisition of shares and takeovers. A reminder advertisement was published on August 7, 2025, in various newspapers. Saffron Capital Advisors Private Limited is managing the offer, with contact information provided for clarifications.
25Jul 25
Shankarappa Nagaraja Vinaya Babu Launches Open Offer for 26% Stake in Pharmaids Pharmaceuticals at ₹62.15 Per Share
Shankarappa Nagaraja Vinaya Babu and Tumkur Trade Center Private Limited have announced an open offer to acquire up to 26% stake in Pharmaids Pharmaceuticals at ₹62.15 per share, valuing the deal at ₹56.99 crore. The offer period is from August 4 to August 18, 2025. The acquirers currently hold a combined 24.36% stake, which could increase to 51.28% post-offer. Most existing promoters will seek reclassification as public shareholders, while the acquirers will become new promoters. Pharmaids Pharmaceuticals, engaged in pharmaceutical and biotechnology services, reported a revenue of ₹1,944.74 lakh and a net loss of ₹1,350.51 lakh for FY ending March 31, 2025.
Pharmaids Pharmaceuticals
48.82
+1.01
(+2.11%)
1 Year Returns:-39.04%
Industry Peers
Sun Pharmaceutical
1,760.70
(-1.23%)
Divis Laboratories
6,600.50
(-0.63%)
Torrent Pharmaceuticals
4,026.40
(-1.61%)
Cipla
1,460.60
(-0.50%)
Dr Reddys Laboratories
1,206.90
(-2.89%)
Lupin
2,190.90
(-1.06%)
Mankind Pharma
2,261.20
(-2.19%)
Zydus Life Science
907.55
(-2.16%)
Aurobindo Pharma
1,206.10
(-2.37%)
Alkem Laboratories
5,793.00
(-0.23%)